Navigation Links
Genzyme Announces Results of Clinical Trial of Hylastan

tains forward-looking statements, including the statements regarding whether and when Synvisc-One obtains marketing approval in the US and the timing of a regulatory filing for Synvisc-One in Europe. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these forward- looking statements. These risks and uncertainties include, among others, the extent to which the US Food and Drug Administration determines that Synvisc- One can appropriately be approved for marketing in the US, our ability to prepare the necessary regulatory filing for Europe in a timely fashion and the risks and uncertainties described in reports filed by Genzyme with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, including without limitation the information under the heading "Risk Factors" in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of the Genzyme Quarterly Report on Form 10-Q for the quarter ending March 31, 2007. Genzyme cautions investors not to place substantial reliance on the forward-looking statements contained in this press release. These statements speak only as of the date of this press release, and Genzyme undertakes no obligation to update or revise the statements.

Genzyme(R) and Synvisc(R) are registered trademarks and Synvisc-One(TM) is a trademark of Genzyme Corporation. All rights reserved.

Genzyme's press releases and other company information are available at www.genzyme.com and by calling Genzyme's investor information line at 1-800-905-4369 within the United States or 1-678-999-4572 outside the United States.


    Media Contact:    Investor Contact:

    Bo Piela          Sally Curley

    (617) 768-6579    (617) 768-6140


CONTACT: Media, Bo Piela, +1-617-768-6579, or Investor, Sally Curley,+1-617-768-6140, bot
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genzyme Announces Results Clinical Trial Hylastan
(Date:8/27/2014)... VANCOUVER, British Columbia and MENLO ... DelMar Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of ... presenting company at the 16th Annual Rodman & Renshaw ... & Co., LLC. The presentation will take place Tuesday, September ... Salon (4th floor) at the New York Palace Hotel ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... "Global Pulse Oximeter Industry Report 2014" report ... Oximeter Industry Report 2014 is a professional and in-depth ... oximeter industry. The report provides a basic ... industry chain structure. The pulse oximeter market analysis is ...
Breaking Medicine Technology:DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Pulse Oximeter Industry Report 2014 2
(Date:8/27/2014)... York (PRWEB) August 27, 2014 The ... ( http://www.consumerinjurylawyers.com/DePuy/ ) has extended the deadline for plaintiffs ... an August 2014 Order issued by U.S. District Judge ... wishing to enroll in the DePuy ASR Settlement Program ... DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation ...
(Date:8/27/2014)... 2014 The extensive polling of ... healthcare research group Black Book Rankings uncovers several ... staffed, supplied or built to care for even ... this annual survey to gain stakeholder insight into ... epidemiology and emergency preparedness systems,” said Doug Brown, ...
(Date:8/27/2014)... Ticket Down is a dependable source for authentic Brazil ... The Brazilian national soccer team will tangle with the ... Stadium in Miami Gardens, Florida. The two South American ... earlier this year when Brazil got the 2-1 win, but ... announced earlier this week that Neymar would return from injury ...
(Date:8/27/2014)... (HealthDay News) -- There,s been controversy for years over ... their pregnancies might raise the odds of mental health ... more than 13,000 children finds no rise in the ... an antidepressant while pregnant, but some data suggesting a ... The findings challenge prior research pointing to a ...
(Date:8/27/2014)... Chicago, Illinois (PRWEB) August 27, 2014 ... the 2014 FIBA World Cup in Spain at ... in their role as FIBA Equipment & Venue Centre Partner ... to 2016. , The six courts will bear the Connor ... by fans around the globe on the ESPN broadcasts of ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 2Health News:Do Antidepressants in Pregnancy Raise Risks for Mental Woes in Kids? 3Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 2Health News:Connor Sports® Provides Six Custom Courts for 2014 FIBA World Cup - Time-Lapse Video of FIBA Courts Production Released 3
... high risk of suffering a stroke, say US researchers. They ... opticians and GPs to mass-screen patients.Strokes are caused by brain ... that are effective at preventing stroke in high-risk patients are ... to their network of blood vessels - their vascular system ...
... have increased risk of stroke due to elevated cholesterol. Much ... stroke has concentrated on men. Now doctors at Columbia University ... of stroke. They looked at over 20,000 women with no ... from 30 to 95 years. The women were followed up ...
... a recent study, spending time in an Indian temple improves ... new study, India, looked at how traditional healing practices might ... South India has long been a healing centre for those ... short period in 1000 were enrolled in the study. ...
... on African tribe, most of the things being equal including ... be healthier for the heart than eating a vegetarian diet. ... body control blood levels of leptin,// a substance secreted by ... risk for heart attack and stroke. ,Lead author of ...
... that high levels of the amino acid homocysteine may ... disease, researchers report. It is still too soon to ... risk of Alzheimer's// and other types of dementia, but ... shown that elevated levels of homocysteine may increase the ...
... darkness might prevent retinal damage in diabetes. One of the ... diabetic retinopathy. This results from damage to the retina //- ... which responds to light.In diabetes, the blood supply to the ... rods (the cells responsible for night vision) which have a ...
Cached Medicine News:Health News:Fish rich diet lowers leptin 2Health News:High Levels of Protein Linked to Brain Shrinkage 2
Cold light source single outlet....
Cold light source single outlet....
Cold light source triple outlet....
Cold light source triple outlet....
Medicine Products: